Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...

Employers are grappling with the ripple effect of an increasingly popular weight loss treatment. Pharmacy benefit leaders at ...

Anti-obesity medication: these are the surprising effects of taking Ozempic and Mounjaro - As weight loss jabs becomes ...

Conversations between the patient and provider should focus on the stakes of antiobesity treatment and continuation, says ...

Cite this: Anti-Obesity Medication Use After Joint Replacement May Reduce Risk for Revision Surgery - Medscape - February 24, 2025. Comments Commenting is limited to medical professionals.

The best way to address employers' concerns is to improve employee utilization of weight loss benefits, according to Saunders ...

Adding an anti-obesity medication alongside behavioral therapy produced significantly more weight loss in patients who initially struggled with the therapy, a study in Nature Medicine showed ...

A new weight loss drug which appears to cause fat cells to create heat, literally burning it away, has been discovered by ...

Eli Lilly's once-weekly KwikPen format for Mounjaro has been approved in India, offering an easier delivery system for type 2 ...

Recent studies demonstrate this clearly. For example, in the SURMOUNT-4 trial involving tirzepatide (Zepbound), participants achieved an average weight loss of 20.9% after 36 weeks on the medication.